Skip to Content
Merck
CN
All Photos(1)

Documents

779008

Sigma-Aldrich

α-Cyclodextrin

Produced by Wacker Chemie AG, Burghausen, Germany, Life Science, 98.0-101.0% cyclodextrin basis (HPLC)

Synonym(s):

Cavamax® W6 Pharma, alpha-Cyclodextrin, α-Schardinger dextrin, Cyclohexaamylose, Cyclomaltohexaose

Sign Into View Organizational & Contract Pricing


About This Item

Empirical Formula (Hill Notation):
C36H60O30
CAS Number:
Molecular Weight:
972.84
Beilstein:
79627
EC Number:
MDL number:
UNSPSC Code:
12352005
PubChem Substance ID:
NACRES:
NA.22

grade

Produced by Wacker Chemie AG, Burghausen, Germany, Life Science

Quality Level

Assay

98.0-101.0% cyclodextrin basis (HPLC)

form

solid

optical activity

[α]/D 147.0 to 152.0° in H2O (USP)

impurities

≤0.20% reducing substances
≤0.25% β- and γ-cyclodextrin (each)
≤0.5% related substances
≤20 ppm residual solvents
≤5 ppm heavy metals (USP)

ign. residue

≤0.10% (USP)

loss

≤10.0% loss on drying

pH

5.0-8.0 (1% in solution)

mp

>278 °C (dec.) (lit.)

absorption

≤0.05 at 350-750 nm in solution at 1%
≤0.10 at 230-250 nm in solution at 1%

suitability

positive for identity (Ph Eur)

SMILES string

OC[C@H]1O[C@@H]2O[C@H]3[C@H](O)[C@@H](O)[C@H](O[C@@H]3CO)O[C@H]4[C@H](O)[C@@H](O)[C@H](O[C@@H]4CO)O[C@H]5[C@H](O)[C@@H](O)[C@H](O[C@@H]5CO)O[C@H]6[C@H](O)[C@@H](O)[C@H](O[C@@H]6CO)O[C@H]7[C@H](O)[C@@H](O)[C@H](O[C@@H]7CO)O[C@H]1[C@H](O)[C@H]2O

InChI

1S/C36H60O30/c37-1-7-25-13(43)19(49)31(55-7)62-26-8(2-38)57-33(21(51)15(26)45)64-28-10(4-40)59-35(23(53)17(28)47)66-30-12(6-42)60-36(24(54)18(30)48)65-29-11(5-41)58-34(22(52)16(29)46)63-27-9(3-39)56-32(61-25)20(50)14(27)44/h7-54H,1-6H2/t7-,8-,9-,10-,11-,12-,13-,14-,15-,16-,17-,18-,19-,20-,21-,22-,23-,24-,25-,26-,27-,28-,29-,30-,31-,32-,33-,34-,35-,36-/m1/s1

InChI key

HFHDHCJBZVLPGP-RWMJIURBSA-N

Looking for similar products? Visit Product Comparison Guide

Related Categories

Application

α-Cyclodextrin can be used:
  • As a ligand in the complexation of nonionic surfactants and polyethylene glycols. α-cyclodextrin shows strong interaction with the surfactants that contains no benzene group.
  • To protect linoleic acid from oxidation.
  • In the synthesis of binuclear copper(II) complexes with cyclodextrins, which can be further used as a template for the preparation of copper nanoparticles incorporated on mesoporous silica.

Legal Information

Cavasol is a registered trademark of Wacker Chemie AG

WGK

WGK 1

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Cucurbituril and α-and β-Cyclodextrins as Ligands for the Complexation of Nonionic Surfactants and Polyethyleneglycols in Aqueous Solutions
Buschmann HJ, et al.
Journal of Inclusion Phenomena and Macrocyclic Chemistry, 37(1-4), 231-236 (2000)
One-step synthesis of copper nanoparticles containing mesoporous silica by nanocasting of binuclear copper (II) complexes with cyclodextrins.
Han B H and Antonietti M
Journal of Materials Chemistry, 13(7), 1793-1796 (2003)
Oxidation-stable linoleic acid by inclusion in α-cyclodextrin
Regiert M, et al.
Journal of Inclusion Phenomena and Macrocyclic Chemistry, 57(1-4), 471-474 (2007)
M C Hamoudi et al.
Journal of controlled release : official journal of the Controlled Release Society, 161(3), 861-867 (2012-05-29)
The purpose of this work was to investigate the potential of α-cyclodextrin combined to soybean oil-based formulations to modulate the release of a model drug, indomethacin. Dry emulsion, naked and coated beads were prepared from the same initial formulation using
Yuya Hayashi et al.
Molecular pharmaceutics, 9(6), 1645-1653 (2012-04-19)
To reveal the potential use of lactosylated-dendrimer (G3) conjugates with α-cyclodextrin (Lac-α-CDE (G3)) as novel hepatocyte-specific siRNA carriers in order to treat transthyretin (TTR)-related familial amyloidotic polyneuropathy (FAP), we evaluated the RNAi effect of siRNA complexes with Lac-α-CDE (G3) both

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service